Usefulness of pindolol for treatment of neurocardiogenic syncope.

Abstract

This study evaluated the efficacy of pindolol, a noncardioselective beta blocker with intrinsic sympathetic activity, on neurocardiogenic syncope using a head-up tilt-table test in 66 patients. Pindolol was equally effective in men and women and the 2 age groups (>60 and <60 years) of the study cohort. The earliest benefit was seen </=3 days after initiating treatment. Side effects were better tolerated in younger patients (age <60 years).

• Authors: Nandini Nair, Farooq A Padder, Steven P Kutalek, Bharat K Kantharia
• Journal: The American journal of cardiology (Am J Cardiol) Vol. 94 Issue 9 Pg. 1189-91 (Nov 01 2004) ISSN: 0002-9149 [Print] United States
• PMID: 15518620 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Adrenergic beta-Antagonists
• Pindolol

Topics

• Adolescent
• Adrenergic beta-Antagonists (therapeutic use)
• Adult
• Age Factors
• Aged
• Aged, 80 and over
• Blood Pressure (drug effects)
• Drug Evaluation
• Female
• Follow-Up Studies
• Heart Rate (drug effects)
• Humans
• Male
• Middle Aged
• Pindolol (therapeutic use)
• Syncope, Vasovagal (drug therapy)
• Tilt-Table Test
• Treatment Outcome